Skandinaviska Enskilda Banken AB publ Sells 100,742 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Skandinaviska Enskilda Banken AB publ reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 19.0% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 429,848 shares of the healthcare conglomerate’s stock after selling 100,742 shares during the quarter. UnitedHealth Group makes up about 1.0% of Skandinaviska Enskilda Banken AB publ’s portfolio, making the stock its 18th largest holding. Skandinaviska Enskilda Banken AB publ’s holdings in UnitedHealth Group were worth $218,904,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Aveo Capital Partners LLC raised its holdings in UnitedHealth Group by 23.8% during the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after purchasing an additional 416 shares during the last quarter. 9258 Wealth Management LLC lifted its holdings in UnitedHealth Group by 7.3% in the fourth quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after buying an additional 290 shares during the period. Gryphon Financial Partners LLC grew its holdings in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after acquiring an additional 2,782 shares during the period. TrinityPoint Wealth LLC lifted its stake in shares of UnitedHealth Group by 102.8% in the 4th quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after purchasing an additional 7,489 shares during the period. Finally, Quest Partners LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $668,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $577.10 on Friday. The firm’s 50-day simple moving average is $575.84 and its two-hundred day simple moving average is $519.83. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $607.94. The firm has a market cap of $532.91 billion, a price-to-earnings ratio of 35.28, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the company posted $6.14 earnings per share. The business’s revenue was up 6.4% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.46%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analyst Ratings Changes

A number of research firms recently issued reports on UNH. Robert W. Baird boosted their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Morgan Stanley increased their price target on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research report on Monday. Truist Financial boosted their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.